✦ LIBER ✦

Advances in Immunotherapy of Multiple Myeloma: From the Discovery of Tumor-Associated Antigens to Clinical Trials

✍ Scribed by Chiriva-Internati, Maurizio; Cobos, Everardo; Kast, W. Martin

Book ID: 118055186
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 315 KB
Volume: 26
Category: Article
ISSN: 0883-0185
DOI: 10.1080/08830180701365966

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Specific active immunotherapy in patient

Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial

✍ Ariel Hollinshead; E. George Elias; Myron Arlen; Barbara Buda; Maria Mosley; Jos 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Twenty-two patients received specific active immunotherapy (TAA vaccine once per month for 3 months), with the duration of follow-up, as of July 1984, ranging from 3 months to 36 months (median, 21 months). Of these, seven had Dukes Bz, seven had Dukes C, and eight had Dukes D lesions. All received

The repertoire of human tumor-associated

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials

✍ Haen, Sebastian P; Rammensee, Hans-Georg 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Results From a Phase 3 Randomized, Doubl

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Extended follow-up of a phase II trial i

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

✍ Paul G. Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jaganna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Addition of thalidomide to oral melphala

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

✍ Meral Beksac; Rauf Haznedar; Tulin Firatli-Tuglular; Hakan Ozdogu; Ismet Aydogdu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Translational research in stroke: Taking

Translational research in stroke: Taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials

✍ Marc Fisher; Nils Henninger 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 161 KB